Össur hf. provided earnings guidance for the year 2024. The company's organic sales growth guidance is 5%-8%, expected to be driven by continued strong volume growth and moderate price increases.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29 DKK | -1.69% | -3.01% | +5.65% |
04-23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
04-23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.65% | 1.78B | |
-11.84% | 20.99B | |
-2.77% | 17.52B | |
+7.94% | 14.19B | |
+8.24% | 10.05B | |
-13.82% | 2.16B | |
+39.43% | 1.65B | |
+23.49% | 642M | |
0.00% | 406M | |
+31.73% | 153M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Provides Earnings Guidance for the Year 2024